Product
QLG2071
1 clinical trial
1 indication
Indication
hypertensive crisisClinical trial
A Multicentre, Randomized, Double-blind, Parallel Design Phase III Study to Evaluate the Efficacy and Safety of Intravenous QLG2071 Versus Cleviprex® for Patients With Hypertensive Emergency and Sub-emergencyStatus: Not yet recruiting, Estimated PCD: 2024-05-24